A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity
2007

N-acetylcysteine and Contrast-Induced Nephrotoxicity

Sample size: 2746 publication Evidence: moderate

Author Information

Author(s): Gonzales Denise A, Norsworthy Kelly J, Kern Steven J, Banks Steve, Sieving Pamela C, Star Robert A, Natanson Charles, Danner Robert L

Primary Institution: National Institutes of Health

Hypothesis

Does N-acetylcysteine effectively prevent contrast-induced nephrotoxicity?

Conclusion

This meta-analysis does not support the efficacy of NAC to prevent contrast-induced nephrotoxicity.

Supporting Evidence

  • Cluster 1 studies showed no benefit from NAC (RR = 0.87; p = 0.28).
  • Cluster 2 studies indicated a large benefit from NAC treatment (RR = 0.15; p < 0.0001).
  • Significant heterogeneity was detected among the trials (I2 = 37%; p = 0.04).
  • Dialysis use across all studies did not suggest that NAC is beneficial (p = 0.42).

Takeaway

N-acetylcysteine (NAC) was tested to see if it helps prevent kidney problems from contrast dye, but it didn't work.

Methodology

The study included a meta-analysis of 22 randomized controlled trials with data extraction and clustering analysis.

Potential Biases

Publication bias was suggested by funnel plot asymmetry.

Limitations

The studies included showed significant heterogeneity and varied in quality.

Participant Demographics

The studies included a total of 2746 patients, with varying demographics across trials.

Statistical Information

P-Value

p = 0.04

Confidence Interval

95% CI 0.68–1.12

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1741-7015-5-32

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication